未登录

E

Eun Sil Kim

Sungkyunkwan University School of Medicine

H指数:13

被引数:1,126

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Subcutaneous versus intravenous double-dose infliximab for dose intensification in young adults with Crohn's disease: a prospective comparative study

皮下注射与静脉注射双倍剂量英夫利西单抗用于克罗恩病年轻成人患者剂量强化的前瞻性比较研究

Digestive and Liver Disease

IF3.8

2026-10-220

OAAI

Hierarchical RAG enhances a pharmacogenomic AI assistant in guideline related queries

层次化RAG增强了与指南相关的药理学基因组学AI助手查询

Computers in Biology and Medicine

IF6.3

2025-11-290

OAAI

Toward personalized therapeutic drug monitoring of ustekinumab in Crohn’s disease: influence of previous exposure to biologics

关于克罗恩病中乌司奴单抗个体化治疗药物监测的研究：先前生物制剂暴露的影响

Therapeutic Advances in Gastroenterology

IF3.4

2025-11-150

OA

Proactive Drug Monitoring Versus Clinically Based Dosing for Endoscopic Healing in Pediatric Crohn’s Disease Receiving Infliximab

主动药物监测与基于临床的给药方案在应用英夫利昔单抗治疗儿童克罗恩病内镜愈合中的比较

Clinical Gastroenterology and Hepatology

IF12

2025-05-140

OAAI

Prediction of deep remission through serum TNF-α level at 1 year of treatment in pediatric Crohn's disease

SCIENTIFIC REPORTS

IF3.9

2025-04-010

OAAI

Impact of brine composition on the selective removal of Ca2+ and Mg2+ via carbonate formation

通过碳酸盐形成对选择性去除Ca2+和Mg2+的卤水组成影响

CHEMICAL ENGINEERING JOURNAL

IF13.2

2025-03-010

PRE

Upadacitinib for Induction of Remission in Pediatric Ulcerative Colitis: An International Multicenter Study

Upadacitinib诱导小儿溃疡性结肠炎缓解: 一项国际多中心研究

JOURNAL OF CROHNS & COLITIS

IF8.7

2024-11-280

PRE

Yerushalmy-Feler, Anat; Spencer, Elizabeth A.; Dolinger, Michael T.; Suskind, David L.; Mitrova, Katarina; Hradsky, Ondrej; Conrad, Maire A.; Kelsen, Judith R.; Uhlig, Holm H.; Tzivinikos, Christos; Ancona, Silvana; Wlazlo, Magdalena; Hackl, Lukas; Shouval, Dror S.; Bramuzzo, Matteo; Urlep, Darja; Olbjorn, Christine; D'Arcangelo, Giulia; Pujol-Muncunill, Gemma; Yogev, Dotan; Kang, Ben; Gasparetto, Marco; Rungo, Christine; Kolho, Kaija-Leena; Hojsak, Iva; Norsa, Lorenzo; Rinawi, Firas; Sansotta, Naire; Magen Rimon, Ramit; Granot, Maya; Scarallo, Luca; Trindade, Eunice; Velasco Rodriguez-Belvis, Marta; Turner, Dan; Cohen, Shlomi

Alpha effect-driven enhancement of CO2 capture kinetics and size-controlled NaHCO3 crystals: Promoter-added NaOH absorbent study

SEPARATION AND PURIFICATION TECHNOLOGY

IF9

2024-09-012

PRE

Synthesis of seawater-derived superhydrophobic calcium carbonate via CO2 mineralization by utilizing L-Arginine/L-Lysine oleate-based self-assembly structures

利用L-精氨酸/L-赖氨酸油酸酯自组装结构CO2矿化合成海水衍生超疏水碳酸钙

CHEMICAL ENGINEERING JOURNAL

IF13.2

2024-06-012

PRE

Comparison of endoscopic healing and durability between infliximab originator and CT-P13 in pediatric patients with inflammatory bowel disease

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-02-221

OAAI

Fecal Calprotectin at Postinduction Is Capable of Predicting Persistent Remission and Endoscopic Healing after 1 Year of Treatment with Infliximab in Pediatric Patients with Crohn's Disease

IF3.2

2023-11-280

OAAI

Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn's Disease: A Pilot Study

IF3.9

2023-09-192

OAAI

Impact of the histologic grade of acute gastrointestinal graft-versus-host disease on outcomes in pediatric patients treated with allogeneic hematopoietic stem cell transplantation

FRONTIERS IN MEDICINE

IF3

2023-08-081

OAAI

Infliximab vs adalimumab: Points to consider when selecting anti-tumor necrosis factor agents in pediatric patients with Crohn's disease

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2023-05-142

OAAI

Free antibodies-to-infliximab are biomarker for predicting the effect of dose intensification in pediatric Crohn's disease patients with secondary loss of response

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY

IF3.4

2023-05-061

OAAI

Impact of 6-month triptorelin formulation on predicted adult height and basal gonadotropin levels in patients with central precocious puberty

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-02-171

OAAI

Cytokine Profile at Diagnosis Affecting Trough Concentration of Infliximab in Pediatric Crohn's Disease

IF3.9

2022-09-234

OAAI

Assessment of Medication Adherence and Pharmacist Intervention Are Important for the Care of Patients with Inflammatory Bowel Disease

IF3.2

2022-09-151

OAAI

How has the disease course of pediatric ulcerative colitis changed throughout the biologics era? A comparison with the IBSEN study

WORLD JOURNAL OF GASTROENTEROLOGY

IF5.4

2022-07-281

OAAI

Transmural healing evaluated by magnetic resonance enterography in paediatric patients with Crohn's disease receiving maintenance treatment with biologics

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2022-07-233

PRE